DP Tashkin

525 total citations
11 papers, 393 citations indexed

About

DP Tashkin is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, DP Tashkin has authored 11 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 4 papers in Physiology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in DP Tashkin's work include Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Asthma and respiratory diseases (4 papers) and Inhalation and Respiratory Drug Delivery (4 papers). DP Tashkin is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Asthma and respiratory diseases (4 papers) and Inhalation and Respiratory Drug Delivery (4 papers). DP Tashkin collaborates with scholars based in United States, Denmark and Netherlands. DP Tashkin's co-authors include William C. Bailey, David Gonzales, Sonia Buist, Richard E. Kanner, Paula Anderson, P. Clements, Ekkehard Beck, David Elashoff, D.E. Furst and Dinesh Khanna and has published in prestigious journals such as The Lancet, Annals of the Rheumatic Diseases and Thorax.

In The Last Decade

DP Tashkin

11 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
DP Tashkin United States 4 263 213 59 47 46 11 393
Swarna Gaddam United States 4 182 0.7× 98 0.5× 19 0.3× 31 0.7× 32 0.7× 5 280
Alfio Pennisi Italy 10 246 0.9× 124 0.6× 31 0.5× 71 1.5× 30 0.7× 13 335
W M Vollmer United States 7 287 1.1× 358 1.7× 13 0.2× 38 0.8× 20 0.4× 8 557
Michael P. Dutro United States 6 186 0.7× 168 0.8× 51 0.9× 41 0.9× 5 0.1× 10 336
Julie Graves Moy United States 3 306 1.2× 219 1.0× 11 0.2× 31 0.7× 52 1.1× 5 437
Erkka Valovirta United Kingdom 11 363 1.4× 165 0.8× 18 0.3× 17 0.4× 21 0.5× 22 548
Jeffrey Wald United States 5 444 1.7× 309 1.5× 25 0.4× 39 0.8× 21 0.5× 9 635
Eleni Karetsi Greece 12 148 0.6× 279 1.3× 23 0.4× 36 0.8× 10 0.2× 33 426
Atsuyoshi Kawagoshi Japan 12 212 0.8× 476 2.2× 13 0.2× 42 0.9× 19 0.4× 30 621
Henna Kupiainen Finland 8 272 1.0× 353 1.7× 10 0.2× 29 0.6× 21 0.5× 10 420

Countries citing papers authored by DP Tashkin

Since Specialization
Citations

This map shows the geographic impact of DP Tashkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DP Tashkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DP Tashkin more than expected).

Fields of papers citing papers by DP Tashkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DP Tashkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DP Tashkin. The network helps show where DP Tashkin may publish in the future.

Co-authorship network of co-authors of DP Tashkin

This figure shows the co-authorship network connecting the top 25 collaborators of DP Tashkin. A scholar is included among the top collaborators of DP Tashkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DP Tashkin. DP Tashkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Sim, Minyoung, DP Tashkin, Dhanita Khanna, et al.. (2017). OP0124 Treatment with cyclophosphamide for systemic sclerosis-related interstitial lung disease does not improve survival after 12 years of follow up. Annals of the Rheumatic Diseases. 76. 104–104. 1 indexed citations
2.
Tashkin, DP. (2015). The safety of anticholinergic bronchodilators for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Drug Safety. 14(11). 1759–1772. 14 indexed citations
3.
Beck, Ekkehard, Huib A.M. Kerstjens, DP Tashkin, et al.. (2014). Tiotropium decreases the risk of exacerbations in patients with symptomatic asthma regardless of baseline characteristics. Pneumologie. 68(S 01). 3 indexed citations
4.
Tashkin, DP, Michael Engel, Ronald Dahl, et al.. (2013). P163 Tiotropium decreases the risk of exacerbations in patients with symptomatic asthma regardless of baseline characteristics including markers of allergic status. Thorax. 68(Suppl 3). A149–A149. 3 indexed citations
5.
Tashkin, DP, Bartolomé R. Celli, D Burkhart, et al.. (2009). Long-Term Efficacy of Tiotropium in Continuing Smokers vs Sustained Ex-Smokers in the UPLIFT Trial.. A6175–A6175. 3 indexed citations
6.
7.
8.
9.
10.
Tashkin, DP, Richard E. Kanner, William C. Bailey, et al.. (2001). Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. The Lancet. 357(9268). 1571–1575. 304 indexed citations
11.
Tashkin, DP, et al.. (1972). Hepatic lactate uptake during decreased liver perfusion and hyposemia. American Journal of Physiology-Legacy Content. 223(4). 968–974. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Swarna Gaddam Breakdown of academic impact, for papers by Alfio Pennisi Breakdown of academic impact, for papers by W M Vollmer Breakdown of academic impact, for papers by Michael P. Dutro Breakdown of academic impact, for papers by Julie Graves Moy Breakdown of academic impact, for papers by Erkka Valovirta Breakdown of academic impact, for papers by Jeffrey Wald Breakdown of academic impact, for papers by Eleni Karetsi Breakdown of academic impact, for papers by Atsuyoshi Kawagoshi Breakdown of academic impact, for papers by Henna Kupiainen
Rankless by CCL
2026